Andrew Conrad built his career at the intersection of science and business, starting with pioneering cheaper HIV screening for blood donations, scaling that work through National Genetics Institute and LabCorp, and later leading Google X's life sciences team, where he brought together experts from fields like physics, biochemistry, and zoology to work on early disease detection. Across projects like the Baseline Study, smart contact lenses, and nanoparticle-based detection, he consistently pushed to shift medicine from treating sickness to catching problems early, often partnering with major institutions like Stanford, MIT, and Novartis rather than trying to build everything alone.